In line with PM Narendra Modi’s vision of Atma Nirbhar Bharat of making India a self-reliant nation, Transasia initiated manufacturing of ErbaLisa COVID-19 IgG test kits at its existing facility in Daman. Further, it will soon start rolling out kits from its ultra-modern manufacturing facility at Andhra Pradesh MedTech Zone (AMTZ), Visakhapatnam. Sprawling over 35,000 sq.ft., the plant is backed by World Health Organization.
The orthopaedic devices industry will continue to be a promising area in the global medical technology space, and is expected to rank third in sales after cardiology and in-vitro diagnostics by 2020.
The CK Birla Hospital for women recently announced the launch of one of India’s most comprehensive breast health facilities, ‘The Breast Centre’ in Gurugram. ...
Pylo Health launched Pylo 802-LTE, a cellular blood pressure monitor designed for patients undergoing remote physiological monitoring (RPM) and is developed of the FDA-cleared...
- Advertisements -
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy
infusion pumps market information in india for the years 2021-22